Deuterium Metabolic Imaging in People with Multiple Sclerosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorUniversity of Aarhus

About this trial

The goal of this case-control study is to investigate glucose brain metabolism in people with multiple sclerosis and age- and sex-matched healthy controls. The main questions it aims to answer are:

* How does brain glucose metabolism in people with multiple sclerosis compare to age- and sex-matched healthy controls? * How is the brain glucose metabolism of people with multiple sclerosis associated with disease severity?

Participants will come in for testing lasting approximately three hours and undergo deuterium metabolic imaging, physical function test, cognitive function test, and answer survey.

Eligibility criteria

Qualifiers

Aged 18-60 years.

Definite Relapsing remitting multiple sclerosis diagnosis according to the most recent diagnostic criteria

Disqualifiers

Pregnancy

Competing neurological, psychiatric, or systemic diseases including diabetes (except prior TIA, unspecific brain MRI findings, hypertension, atherosclerosis and hyperlipidemia/cholesterolemia which are allowed).

Participating in other clinical trials with investigational medical products or drugs.

Trial design

Treatments tested in this trial

  • No Interventions

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators